Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    11555830 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Preferred Treatment of Type 1.5 Diabetes
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: rosiglitazone;   Drug: glyburide

Study has passed its completion date and status has not been verified in more than two years.